Bhutan vs Singapore: Proportion of isolates with decreased susceptibility or resistance
Bhutan
1
in 2020
Singapore
2.2
in 2020
Bhutan rank
8th
Singapore rank
6th
Proportion of isolates with decreased susceptibility or resistance over time
- Bhutan
- Singapore
How they compare
Singapore currently reports 2.2 against 1 in Bhutan, a difference of 1.2.
That makes Singapore's figure about 2.2 times Bhutan's.
The two have swapped places 4 times across 9 shared years of data; in 2009 it was Singapore ahead.
Bhutan ranks 8th and Singapore ranks 6th of 52 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 1.25 | 1.25 | Singapore |
| 2010s | 1.74 | 2.87 | 1.13 | Singapore |
| 2020s | 1 | 2.2 | 1.2 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Bhutan or Singapore?
- Singapore, at 2.2 against 1 in Bhutan as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Bhutan and Singapore?
- 1.2, with Singapore ahead.
- How many years of comparable data are there for Bhutan and Singapore?
- 9 years are reported by both, from 2009 to 2020.
- How do Bhutan and Singapore rank globally for proportion of isolates with decreased susceptibility or resistance?
- Bhutan ranks 8th and Singapore ranks 6th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.